Fisher Asset Management’s Integra LifeSciences IART Stock Holding History

Fisher Asset Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-47,198	Closed	-$676K	–	1066
2025 Q3	$676K	Hold	47,198	–	–	﹤0.01%	735
2025 Q2	$579K	Hold	47,198	–	–	﹤0.01%	772
2025 Q1	$1.04M	Hold	47,198	–	–	﹤0.01%	676
2024 Q4	$1.07M	Sell	47,198 -352,525	-88%	-$7.69M	﹤0.01%	656
2024 Q3	$7.26M	Hold	399,723	–	–	﹤0.01%	451
2024 Q2	$11.6M	Buy	399,723 +3,529	+0.9%	+$105K	0.01%	401
2024 Q1	$14M	Sell	396,194 -1,598	-0.4%	-$63.9K	0.01%	374
2023 Q4	$17.3M	Sell	397,792 -72,615	-15%	-$2.86M	0.01%	345
2023 Q3	$18M	Sell	470,407 -95,690	-17%	-$4.03M	0.01%	361
2023 Q2	$23.3M	Buy	566,097 +14,114	+3%	+$679K	0.01%	345
2023 Q1	$31.7M	Sell	551,983 -24,413	-4%	-$1.38M	0.02%	308
2022 Q4	$32.3M	Sell	576,396 -184	-0%	-$9.37K	0.02%	292
2022 Q3	$24.4M	Sell	576,580 -1,399	-0.2%	-$71.7K	0.02%	314
2022 Q2	$31.2M	Sell	577,979 -17,461	-3%	-$1.05M	0.02%	268
2022 Q1	$38.3M	Sell	595,440 -6,611	-1%	-$435K	0.02%	261
2021 Q4	$40.3M	Sell	602,051 -7,483	-1%	-$506K	0.02%	268
2021 Q3	$41.7M	Sell	609,534 -24,638	-4%	-$1.74M	0.03%	251
2021 Q2	$43.3M	Sell	634,172 -10,010	-2%	-$708K	0.03%	244
2021 Q1	$44.5M	Sell	644,182 -32,572	-5%	-$2.21M	0.03%	242
2020 Q4	$43.9M	Buy	676,754 +4,083	+0.6%	+$220K	0.03%	234
2020 Q3	$31.8M	Sell	672,671 -6,759	-1%	-$322K	0.03%	238
2020 Q2	$31.9M	Sell	679,430 -32,552	-5%	-$1.6M	0.03%	233
2020 Q1	$31.8M	Buy	711,982 +14,272	+2%	+$749K	0.04%	208
2019 Q4	$40.7M	Sell	697,710 -30,348	-4%	-$1.81M	0.04%	209
2019 Q3	$43.7M	Sell	728,058 -53,108	-7%	-$3.16M	0.05%	206
2019 Q2	$43.6M	Buy	781,166 +5,698	+0.7%	+$293K	0.05%	210
2019 Q1	$43.2M	Sell	775,468 -170,151	-18%	-$8.67M	0.05%	199
2018 Q4	$42.6M	Buy	945,619 +5,179	+0.6%	+$284K	0.06%	194
2018 Q3	$61.9M	Sell	940,440 -5,777	-0.6%	-$359K	0.08%	173
2018 Q2	$60.9M	Sell	946,217 -10,613	-1%	-$657K	0.08%	173
2018 Q1	$53M	Sell	956,830 -38,560	-4%	-$2.02M	0.07%	191
2017 Q4	$47.6M	Sell	995,390 -9,865	-1%	-$483K	0.06%	206
2017 Q3	$50.7M	Sell	1,005,255 -4,805	-0.5%	-$247K	0.07%	188
2017 Q2	$55.1M	Sell	1,010,060 -21,250	-2%	-$1.01M	0.08%	179
2017 Q1	$43.4M	Sell	1,031,310 -11,350	-1%	-$485K	0.07%	191
2016 Q4	$44.7M	Sell	1,042,660 -10,150	-1%	-$413K	0.08%	176
2016 Q3	$43.5M	Buy	1,052,810 +46,080	+5%	+$1.93M	0.08%	171
2016 Q2	$40.5M	Sell	1,006,730 -83,060	-8%	-$2.99M	0.08%	173
2016 Q1	$36.4M	Sell	1,089,790 -14,600	-1%	-$455K	0.07%	178
2015 Q4	$37.4M	Buy	1,104,390 +1,200	+0.1%	+$37.5K	0.07%	177
2015 Q3	$32.8M	Sell	1,103,190 -155,720	-12%	-$4.87M	0.07%	185
2015 Q2	$34.7M	Sell	1,258,910 -13,745	-1%	-$366K	0.07%	191
2015 Q1	$32.1M	Sell	1,272,655 -41,406	-3%	-$979K	0.06%	200
2014 Q4	$29.1M	Sell	1,314,061 -29,089	-2%	-$590K	0.06%	209
2014 Q3	$27.3M	Buy	1,343,150 +41,076	+3%	+$818K	0.06%	192
2014 Q2	$25M	Sell	1,302,074 -102,727	-7%	-$1.91M	0.05%	201
2014 Q1	$26.4M	Sell	1,404,801 -26,911	-2%	-$519K	0.06%	190
2013 Q4	$27.9M	Sell	1,431,712 -54,556	-4%	-$1M	0.06%	193
2013 Q3	$24.5M	Buy	1,486,268 +2,691	+0.2%	+$43.2K	0.06%	198
2013 Q2	$22.2M	Buy	+1,483,577	New	+$21.7M	0.06%	195

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Fisher Asset Management's IART Position: Q4 2025 in Review

Fisher Asset Management sold out of Integra LifeSciences (IART) in Q4 2025, closing a stake of 47,198 shares — an estimated $676K sold.

Fisher Asset Management first reported a position in IART in Q2 2013 and held it in 50 quarters. The position peaked at $61.9M in Q3 2018. 204 funds tracked by Wall St. Rank hold IART as of Q4 2025.

Fisher Asset Management reported no remaining Integra LifeSciences position as of Q4 2025 after selling out during the quarter.
Fisher Asset Management sold 47,198 Integra LifeSciences shares in Q4 2025, an estimated $676K.
Fisher Asset Management first reported a position in Integra LifeSciences in Q2 2013 and held it in 50 quarters.
Fisher Asset Management's Integra LifeSciences position peaked at $61.9M in Q3 2018.
204 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2025.

Based on Fisher Asset Management's 13F filing for Q4 2025, filed 9 Feb 2026.